Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial.
暂无分享,去创建一个
W. Hiddemann | T. Haferlach | C. Schoch | W. Kern | W. Berdel | A. Heinecke | W. Gassmann | M. Sauerland | H. Loffler | T. Buchner